English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Glaxo Smith Kline
Bree Gonzales
| Feb 2, 2022
Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Trending
+
Pharmaceuticals
Patient Daily
| Jun 2, 2025
PathAI collaborates with Northwestern Medicine on digital pathology advancements
+
Regulatory
Patient Daily
| May 30, 2025
Alliance for Pharmacy Compounding calls for eliminating redundant, unauthorized, or ineffective regulation
+
Pharmaceuticals
Patient Daily
| Jun 5, 2025
Exon 20 Group questions effectiveness of 340B drug program
+
Pharmaceuticals
Patient Daily
| Jun 5, 2025
New study identifies indicators for HER2+ breast cancer therapy response
